Home › Schizophrenia › Alabama
Schizophrenia clinical trials in Alabama
4 studies for Schizophrenia are looking for participants at sites in Alabama.
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0054, Dothan
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
- University of Alabama at Birmingham, Birmingham
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Aug 31, 2026 · NCT06911723Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Dothan
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064Biomarkers to Enhance Early Schizophrenia Treatment
- The University of Alabama at Birmingham, Birmingham
RecruitingPhase 4
Ages 18 to 35 · All sexes · Updated Jul 31, 2026 · NCT06969755From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.